[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cognitive-health\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cognitive-health":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,44,73,100],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100650706","a-clinical-trial-to-evaluate-the-effects-of-an-omega-3-containing-supplement-on-dha-and-epa-levels-in-the-blood-100650706",false,"NCT07753174","A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood","Inclusion Criteria:\n\n* Be male or female.\n* Be aged 18-65.\n* Anyone in good general health.\n* Willing to avoid taking other supplements, prescription medications, or herbal remedies that target DHA or EPA levels in the body, for the duration of the study.\n* Must not have taken fish oil or plant-based omega oil supplements in the past eight weeks.\n* Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.\n* Resides in the United States.\n\nExclusion Criteria:\n\n* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.\n* Anyone on anticoagulants or antiplatelet therapy.\n* Anyone with a bleeding disorder.\n* Anyone with any allergies or sensitivities to any of the study product ingredients.\n* Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).\n* Anyone unwilling to follow the study protocol.\n* Anyone who does not consume any specific dietary ingredients for any reason.\n* Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.",true,"ALL","18 Years","65 Years",{"count":20,"type":21},49,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a 12-week, hybrid, single-arm clinical trial designed to evaluate the effects of an omega-3-containing supplement (Omega Active) on DHA and EPA levels in the blood. Forty participants will take two capsules of the test product daily and complete study-specific questionnaires at Baseline, Week 4, Week 8, and Week 12, while also attending their local Quest Diagnostics Center at Baseline and Week 12 for blood biomarker testing.\n\nThe study will also assess participants' perceptions of the effects of the test product on cognitive performance, gastrointestinal symptoms, and overall health through self-reported questionnaires. There is no randomization or blinding; all participants will receive the active supplement for the full 12-week intervention period.",[27,28,29,30],"Omega-3 Deficiency","DHA and EPA Blood Levels","Cardiovascular Health","Cognitive Health","RECRUITING","2026-08-03",{"date":34,"type":35},"2026-08-07","ACTUAL",{"date":37,"type":21},"2026-09",{"date":39,"type":21},"2026-12",{"name":41,"class":42},"Revive Active","INDUSTRY",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":15,"sex":16,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":43},"100586952","the-reminder4care-program-for-older-adults-supported-by-residential-and-daycare-facilities-100586952","NCT06922071","The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities","REMINDER4Care","Inclusion Criteria:\n\n* Aged 65 years and older\n* RDF users\n* Elementary reading and writing skills\n\nExclusion Criteria:\n\n* Have a clinical diagnosis of dementia and\u002For Mini-Mental State Examination (MMSE) scores below the cutoff for the presence of dementia (MMSE \\\u003C 22-27, depending on education level)\n* Have a psychiatric or neurological condition that impairs cognition in the long term\n* Have sensory and functional deficits that compromise their participation in the neuropsychological assessment and throughout the intervention sessions",{"count":52,"type":21},100,[24],"Dementia incidence is rising, posing a public health challenge, but 45% of cases can be prevented by addressing modifiable risk factors. Multidomain trials show that lifestyle changes can improve cognitive function and reduce dementia risk (like the FINGER trial). The REMINDER program, a Portuguese-based dementia risk reduction protocol, was developed for community-dwelling older adults aged 55 and above. However, older adults in Residential and Daycare Facilities (RDF) have distinct needs that demand program adaptation to ensure its relevance and effectiveness. In addition, more studies are needed to evaluate the impact of multidomain interventions with older adults in RDF.\n\nTo address these challenges, the REMINDER4Care program was developed as a tailored, multidomain intervention to reduce dementia risk. It emphasizes social and cognitive engagement and advances its adaptation and evaluation in Residential and Daycare Facilities (RDF). To assess efficacy, the investigators will perform a Randomized Controlled Trial.",[56,57,30],"Dementia Risk Factors","Prevention",[56,57,59,60,61,62],"Health","Aging","Residential and Daycare Facilities","Lifestyle","2026-04-27",{"date":65,"type":35},"2026-05-01",{"date":67,"type":35},"2025-05-01",{"date":69,"type":21},"2026-12-31",{"name":71,"class":72},"University of Coimbra","OTHER",{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":15,"sex":16,"minAge":81,"maxAge":82,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":85,"briefSummary":87,"conditions":88,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":99},"100569566","phase-4-modulation-of-the-brain-fog-scale-by-eicosapentaenoic-acid-monoglycerides-mag-epa-100569566","NCT06695910","Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).","Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA) in Volunteers Who Reported Suffering From Haze or Mental Fatigue on a Regular Basis. Exploratory Study (NBF-MG01).","NBF-MG01","Inclusion Criteria:\n\n1. Participant between 19 and 55 years of age.\n2. Participant who reports having mental fatigue and\u002For frequent memory loss and\u002For difficulty concentrating and\u002For inattention, confusion and\u002For a feeling of decreased cognitive acuity for at least 28 days at the time of selection.\n3. Participant who obtains a mean score on the BFS screening questionnaires (BFS1 and BFS2) total of at least 30 and\u002FOR who obtains the following minimum score on at least one of the three factors: Factor 1 of at least 15 and\u002For Factor 2 of at least 15 and\u002For Factor 3 of at least 12.\n4. Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.\n5. Absence of intellectual problems likely to limit the validity of consent to participate in the study or the compliance with protocol requirements, ability to cooperate adequately, ability to understand and observe the instructions of the research staff.\n6. Participant having no difficulty in swallowing tablets, capsules or gelcaps.\n\nExclusion Criteria:\n\n1. Known allergy or intolerance to fish or history of allergic reactions attributable to fish, or to a compound similar to fish oil.\n2. Participant who has used omega-3 supplements in the 30 days preceding day 1 of the study.\n3. Pregnant or breastfeeding woman as declared by the latter.\n4. Presence of dependence on drugs of abuse or alcohol (˃ 3 units of alcohol per day, acute or chronic excessive consumption).\n5. Participant included in another clinical study and who is receiving an investigational product or other research treatment.","19 Years","55 Years",{"count":84,"type":21},48,[86],"PHASE4","A growing body of studies shows that omega-3s act directly in molecular signaling pathways that reduce inflammation and are thought to have a positive effect on cognitive health. Brain fog is a term that has been popularized in the medical world in the wake of the COVID-19 pandemic. A significant proportion of patients with long COVID reported having cognitive sequelae that were like fogginess. It is defined as a cognitive impairment with characteristic symptoms including problems with concentration, attention and memory, confusion, difficulty understanding what others are saying, reduced mental acuity and mental fatigue. These are episodes of reduced cognitive capacity that are not representative of the person's normal state. This condition can be caused by various factors such as stress, lack of sleep, overwork, depression, hormonal changes due to pregnancy or menopause in women, head injuries, migraine, certain diseases or viral infections, certain medications as well as substance abuse (alcohol and\u002For street drugs). In this study, we want to test whether omega-3 monoglycerides (MAG-EPA) can modulate the cognitive health of people with brain fog.",[89,30],"Brain Fog","2025-12-04",{"date":92,"type":35},"2025-12-11",{"date":94,"type":35},"2024-11-06",{"date":96,"type":21},"2027-07-01",{"name":98,"class":42},"Samuel Fortin",2,{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":104,"acronym":4,"eligibilityCriteria":105,"healthyVolunteers":15,"sex":16,"minAge":106,"maxAge":4,"enrollmentInfo":107,"targetDuration":4,"studyType":109,"phases":4,"briefSummary":110,"conditions":111,"keywords":125,"overallStatus":148,"whyStopped":4,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":4},"100609070","healthspan-connect-programme-of-research-100609070","NCT07209774","Healthspan Connect Programme of Research","Inclusion Criteria:\n\n* Age 12 years or older at time of enrollment.\n* Resident in the United Kingdom.\n* Able to participate in the study using digital tools (smartphone, tablet, or computer).\n* Able to provide informed consent (digital consent accepted).\n* For participants aged 12-15 years: must have parent\u002Fguardian consent in addition to their own assent.\n\nExclusion Criteria:\n\n* Individuals unable to provide informed consent (or parental consent where applicable).\n* Individuals not resident in the UK.\n* Individuals unable to complete study requirements due to lack of internet access, inability to use digital devices, or severe digital literacy barriers.","12 Years",{"count":108,"type":21},100000,"OBSERVATIONAL","Healthspan Connect is a new research programme designed to understand what helps people stay healthy as they age. The programme will explore how lifestyle, environment, genetics, and social factors influence healthy ageing and overall wellbeing.\n\nThe programme will recruit participants aged 12 years and older across the UK. By including adolescents, the programme aims to understand how early life behaviours and experiences shape long-term health. There is no upper age limit, and people from all backgrounds are encouraged to participate. Special pathways ensure that young participants provide consent in an age-appropriate way.\n\nHealthspan Connect is a digital and home-based study, meaning participants can take part from home using smartphones, computers, and online surveys. Participants may also be asked to collect samples such as blood, saliva, stool, urine, or other biological specimens at home using easy-to-use kits. In some sub-studies, participants may be invited to attend research visits for additional tests, scans, or clinical assessments. Family members and close contacts may also be invited to participate in some studies.\n\nThrough Healthspan Connect, researchers aim to:\n\n* Identify the biological, environmental, and social factors that help people live longer, healthier lives.\n* Understand how different groups, including those historically underrepresented in research, experience ageing.\n* Explore ways to support behaviour changes that improve health over the lifespan.\n* Provide near real-time information to inform health policies and interventions.\n\nParticipants may also be asked for permission to link their information with health records, education records, and environmental data to better understand health outcomes over time.\n\nThis programme will serve as a flexible platform for multiple sub-studies, allowing participants to contribute to a wide range of research questions related to healthy ageing, resilience, and long-term health. All data and biological samples will be stored securely and used to advance scientific knowledge, with participant privacy carefully protected.",[112,113,114,115,30,116,117,29,118,119,120,121,122,123,124],"Cancer","Mental Health","Ageing Well","Resilience","Psychological Health","Environmental Health Effects","Metabolic Health","Neurological Health","Musculoskeletal Health","Respiratory Health","Allergies","Eye Health","Other",[126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147],"Healthy ageing","Healthspan","Longevity","Ageing resilience","Life course determinants","Multiple long-term conditions","Digital health research","Remote monitoring","Mobile health (mHealth)","Wearables","Biobank","Biological specimen collection","Home-based sample collection","Epidemiology","Longitudinal cohort study","Adolescents and ageing","Underrepresented populations in research","Behaviour change","Environmental exposures","Data linkage","Electronic health records (EHR)","United Kingdom","NOT_YET_RECRUITING","2025-09-29",{"date":151,"type":35},"2025-10-07",{"date":153,"type":21},"2026-01-05",{"date":155,"type":21},"2056-01-05",{"name":157,"class":72},"King's College London"]